• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Preexisting anti-PF4 antibodies are not further triggered upon vaccination with SARS-CoV-2 vector vaccines in a cohort of 400 health care workers.

作者信息

Angelika Wagner, Erika Garner-Spitzer, Michael Kundi, Hannes Stockinger, Ingrid Pabinger, Sabine Eichinger-Hasenauer, Peter Quehenberger, Oswald Wagner, Ursula Wiedermann, Katharina Grabmeier-Pfistershammer

机构信息

Medical University of Vienna, Centre for Pathophysiology, Infectiology and Immunology, Institute of Specific Prophylaxis and Tropical Medicine, Vienna, Austria.

Medical University of Vienna, Centre for Public Health, Vienna, Austria.

出版信息

Thromb Res. 2022 Oct;218:142-144. doi: 10.1016/j.thromres.2022.08.005. Epub 2022 Aug 11.

DOI:10.1016/j.thromres.2022.08.005
PMID:36037550
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9367206/
Abstract
摘要

相似文献

1
Preexisting anti-PF4 antibodies are not further triggered upon vaccination with SARS-CoV-2 vector vaccines in a cohort of 400 health care workers.在一个由400名医护人员组成的队列中，接种新冠病毒载体疫苗后，预先存在的抗PF4抗体不会被进一步触发。
Thromb Res. 2022 Oct;218:142-144. doi: 10.1016/j.thromres.2022.08.005. Epub 2022 Aug 11.
2
Inflammation and Platelet Activation After COVID-19 Vaccines - Possible Mechanisms Behind Vaccine-Induced Immune Thrombocytopenia and Thrombosis.新冠病毒疫苗接种后的炎症和血小板活化 - 疫苗诱导免疫性血小板减少症和血栓形成的可能机制。
Front Immunol. 2021 Nov 23;12:779453. doi: 10.3389/fimmu.2021.779453. eCollection 2021.
3
Antibody responses after a single dose of ChAdOx1 nCoV-19 vaccine in healthcare workers previously infected with SARS-CoV-2.在先前感染过 SARS-CoV-2 的医护人员中，单次接种 ChAdOx1 nCoV-19 疫苗后的抗体反应。
EBioMedicine. 2021 Aug;70:103523. doi: 10.1016/j.ebiom.2021.103523. Epub 2021 Aug 12.
4
Tolerability and immunogenicity of an intranasally-administered adenovirus-vectored COVID-19 vaccine: An open-label partially-randomised ascending dose phase I trial.鼻内接种腺病毒载体 COVID-19 疫苗的耐受性和免疫原性：一项开放性、部分随机、递增剂量的 I 期临床试验。
EBioMedicine. 2022 Nov;85:104298. doi: 10.1016/j.ebiom.2022.104298. Epub 2022 Oct 10.
5
Low clinical utility of testing for anti-platelet factor 4 in asymptomatic individuals after ChAdOx1 nCoV-19 vaccine.在接种 ChAdOx1 nCoV-19 疫苗后无症状个体中检测抗血小板因子 4 的临床实用性低。
Int J Lab Hematol. 2022 Apr;44(2):424-429. doi: 10.1111/ijlh.13774. Epub 2021 Nov 30.
6
No Correlation between Anti-PF4 and Anti-SARS-CoV-2 Antibodies after ChAdOx1 nCoV-19 Vaccination.ChAdOx1 nCoV-19疫苗接种后抗PF4抗体与抗SARS-CoV-2抗体之间无相关性。
N Engl J Med. 2021 Sep 30;385(14):1334-1336. doi: 10.1056/NEJMc2111305. Epub 2021 Aug 25.
7
Early Safety Monitoring of COVID-19 Vaccines in Healthcare Workers.医护人员 COVID-19 疫苗的早期安全性监测。
J Korean Med Sci. 2021 Apr 19;36(15):e110. doi: 10.3346/jkms.2021.36.e110.
8
Interdependencies of cellular and humoral immune responses in heterologous and homologous SARS-CoV-2 vaccination.细胞和体液免疫应答在异源和同源 SARS-CoV-2 疫苗接种中的相互关系。
Allergy. 2022 Aug;77(8):2381-2392. doi: 10.1111/all.15247. Epub 2022 Feb 16.
9
MOG encephalomyelitis after vaccination against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2): case report and comprehensive review of the literature.接种 2019 年冠状病毒病（SARS-CoV-2）疫苗后发生 MOG 脑炎：病例报告及文献综述。
J Neurol. 2022 Oct;269(10):5198-5212. doi: 10.1007/s00415-022-11194-9. Epub 2022 Jun 23.
10
An Argentinean cohort of patients with rheumatic and immune-mediated diseases vaccinated for SARS-CoV-2: the SAR-CoVAC Registry-protocol and preliminary data.一项针对风湿和免疫介导性疾病患者的阿根廷队列研究：SARS-CoV-2 疫苗接种：SAR-CoVAC 注册研究方案和初步数据。
Clin Rheumatol. 2022 Oct;41(10):3199-3209. doi: 10.1007/s10067-022-06253-5. Epub 2022 Jun 28.

本文引用的文献

1
Epidemiology of VITT.VITT 的流行病学。
Semin Hematol. 2022 Apr;59(2):72-75. doi: 10.1053/j.seminhematol.2022.02.002. Epub 2022 Feb 8.
2
Most anti-PF4 antibodies in vaccine-induced immune thrombotic thrombocytopenia are transient.大多数疫苗诱导的免疫性血栓性血小板减少症中的抗 PF4 抗体是一过性的。
Blood. 2022 Mar 24;139(12):1903-1907. doi: 10.1182/blood.2021014214.
3
Insights in ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia.腺病毒载体新冠疫苗诱导的免疫性血栓性血小板减少症的相关认识。
Blood. 2021 Dec 2;138(22):2256-2268. doi: 10.1182/blood.2021013231.
4
Vaccine-Induced Thrombocytopenia with Severe Headache.疫苗诱导的血小板减少症伴严重头痛
N Engl J Med. 2021 Nov 25;385(22):2103-2105. doi: 10.1056/NEJMc2112974. Epub 2021 Sep 15.
5
Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis.疫苗诱导的免疫性血小板减少症和血栓形成的临床特征。
N Engl J Med. 2021 Oct 28;385(18):1680-1689. doi: 10.1056/NEJMoa2109908. Epub 2021 Aug 11.
6
Frequency of positive anti-PF4/polyanion antibody tests after COVID-19 vaccination with ChAdOx1 nCoV-19 and BNT162b2.接种 ChAdOx1 nCoV-19 和 BNT162b2 疫苗后抗 PF4/多阴离子抗体检测阳性的频率。
Blood. 2021 Jul 29;138(4):299-303. doi: 10.1182/blood.2021012217.
7
An observational study to identify the prevalence of thrombocytopenia and anti-PF4/polyanion antibodies in Norwegian health care workers after COVID-19 vaccination.一项观察性研究旨在确定挪威医护人员在接种 COVID-19 疫苗后血小板减少症和抗 PF4/多阴离子抗体的流行情况。
J Thromb Haemost. 2021 Jul;19(7):1813-1818. doi: 10.1111/jth.15352. Epub 2021 May 18.
8
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination.接种 ChAdOx1 nCov-19 疫苗后发生血栓性血小板减少症。
N Engl J Med. 2021 Jun 3;384(22):2092-2101. doi: 10.1056/NEJMoa2104840. Epub 2021 Apr 9.
9
COVID-19 patients often show high-titer non-platelet-activating anti-PF4/heparin IgG antibodies.COVID-19 患者常表现出高滴度非血小板活化抗 PF4/肝素 IgG 抗体。
J Thromb Haemost. 2021 May;19(5):1294-1298. doi: 10.1111/jth.15262. Epub 2021 Apr 7.
10
Cerebral Venous Sinus Thrombosis in COVID-19 Infection: A Case Series and Review of The Literature.新型冠状病毒感染相关脑静脉窦血栓形成：病例系列研究及文献复习。
J Stroke Cerebrovasc Dis. 2021 Jan;30(1):105434. doi: 10.1016/j.jstrokecerebrovasdis.2020.105434. Epub 2020 Nov 6.